Home | | Pharmacology | Anti-Ige Monoclonal Antibody

Chapter: Basic & Clinical Pharmacology : Drugs Used in Asthma

Anti-Ige Monoclonal Antibody

Treatment with omalizumab, the monoclonal humanized anti-IgE antibody.

ANTI-IGE MONOCLONAL ANTIBODY

Treatment with omalizumab, the monoclonal humanized anti-IgE antibody, is reserved for patients with chronic severe asthma inad-equately controlled by high-dose inhaled corticosteroid plus long-acting β-agonist combination treatment (eg, fluticasone, 500 mcg, plus salmeterol, 50 mcg, inhaled twice daily). Omalizumab reduces lymphocytic, eosinophilic bronchial inflammation and effectively reduces the frequency and severity of exacerbations. It is reserved for patients with demonstrated IgE-mediated sensitiv-ity (by positive skin test or radioallergosorbent test [RAST] to common allergens) and an IgE level within a range that can be reduced sufficiently by twice-weekly subcutaneous injection.


Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail
Basic & Clinical Pharmacology : Drugs Used in Asthma : Anti-Ige Monoclonal Antibody |


Privacy Policy, Terms and Conditions, DMCA Policy and Compliant

Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.